CL2017000152A1 - Derivados de isoindolinona - Google Patents

Derivados de isoindolinona

Info

Publication number
CL2017000152A1
CL2017000152A1 CL2017000152A CL2017000152A CL2017000152A1 CL 2017000152 A1 CL2017000152 A1 CL 2017000152A1 CL 2017000152 A CL2017000152 A CL 2017000152A CL 2017000152 A CL2017000152 A CL 2017000152A CL 2017000152 A1 CL2017000152 A1 CL 2017000152A1
Authority
CL
Chile
Prior art keywords
isoindolinone derivatives
isoindolinone
derivatives
compounds
understand
Prior art date
Application number
CL2017000152A
Other languages
English (en)
Inventor
Brian Alvin Johns
Emile Johann Velthuisen
Jason Gordon Weatherhead
Original Assignee
Viiv Healthcare Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare Uk Ltd filed Critical Viiv Healthcare Uk Ltd
Publication of CL2017000152A1 publication Critical patent/CL2017000152A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<p> </p> <p>SE DAN A CONOCER COMPUESTOS DE LA FÓRMULA I  Y MÉTODOS PARA EL TRATAMIENTO DE INFECCIONES VIRALES CON COMPOSICIONES QUE COMPRENDEN ESTOS COMPUESTOS.</p>
CL2017000152A 2014-07-22 2017-01-19 Derivados de isoindolinona CL2017000152A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462027359P 2014-07-22 2014-07-22

Publications (1)

Publication Number Publication Date
CL2017000152A1 true CL2017000152A1 (es) 2017-07-28

Family

ID=53718075

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000152A CL2017000152A1 (es) 2014-07-22 2017-01-19 Derivados de isoindolinona

Country Status (17)

Country Link
US (1) US10118894B2 (es)
EP (1) EP3172200B1 (es)
JP (1) JP2017521458A (es)
KR (1) KR20170032338A (es)
CN (1) CN106536513A (es)
AR (1) AR101255A1 (es)
AU (1) AU2015293506B2 (es)
CA (1) CA2954733A1 (es)
CL (1) CL2017000152A1 (es)
ES (1) ES2703352T3 (es)
IL (1) IL249581A0 (es)
PT (1) PT3172200T (es)
RU (1) RU2017103656A (es)
TW (1) TW201617315A (es)
UY (1) UY36221A (es)
WO (1) WO2016012930A1 (es)
ZA (1) ZA201608511B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9975906B2 (en) 2014-05-16 2018-05-22 Shionogi & Co., Ltd. Tricyclic heterocycle derivatives having HIV replication inhibitory effect
TWI700284B (zh) 2015-05-29 2020-08-01 日商塩野義製藥股份有限公司 具有ｈｉｖ複製抑制作用之含氮３環性衍生物
US20190284136A1 (en) 2016-07-25 2019-09-19 Viiv Healthcare Uk Limited Indoline derivatives
WO2020102198A1 (en) 2018-11-13 2020-05-22 Incyte Corporation Heterocyclic derivatives as pi3k inhibitors
WO2020102150A1 (en) 2018-11-13 2020-05-22 Incyte Corporation Heterocyclic derivatives as pi3k inhibitors
WO2020102216A1 (en) 2018-11-13 2020-05-22 Incyte Corporation Substituted heterocyclic derivatives as pi3k inhibitors
WO2022187521A1 (en) * 2021-03-03 2022-09-09 The Curators Of The University Of Missouri Suppression of covid-19 replication by covid-19 entry inhibitors
CN115160211B (zh) * 2022-06-23 2023-11-03 温州大学 一种异吲哚啉酮类化合物的绿色合成方法
KR20240049492A (ko) 2022-10-08 2024-04-16 임서윤 문어발 건조대

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009026248A2 (en) * 2007-08-17 2009-02-26 The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
EA019259B1 (ru) 2007-11-16 2014-02-28 Джилид Сайенсиз, Инк. Ингибиторы репликации вируса иммунодефицита человека
EP2511273B8 (en) * 2011-04-15 2019-06-26 Hivih Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2013012649A1 (en) 2011-07-15 2013-01-24 Glaxosmithkline Llc Azaindole compounds and methods for treating hiv
WO2013016441A1 (en) * 2011-07-26 2013-01-31 The United States of America, represented by The Secretary, Department of Health & Human Services Hiv integrase inhibitory oxoisoindoline sulfonamides
US9284323B2 (en) * 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
US9006235B2 (en) * 2012-03-06 2015-04-14 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
UY34750A (es) * 2012-04-20 2013-11-29 Gilead Sciences Inc ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CA2876370A1 (en) * 2012-07-12 2014-01-16 Viiv Healthcare Uk Limited Compounds and methods for treating hiv

Also Published As

Publication number Publication date
JP2017521458A (ja) 2017-08-03
RU2017103656A (ru) 2018-08-22
IL249581A0 (en) 2017-02-28
RU2017103656A3 (es) 2018-11-07
PT3172200T (pt) 2019-01-17
EP3172200A1 (en) 2017-05-31
EP3172200B1 (en) 2018-10-17
AR101255A1 (es) 2016-12-07
ES2703352T3 (es) 2019-03-08
CA2954733A1 (en) 2016-01-28
AU2015293506B2 (en) 2017-08-17
AU2015293506A1 (en) 2017-01-12
WO2016012930A1 (en) 2016-01-28
US10118894B2 (en) 2018-11-06
ZA201608511B (en) 2019-06-26
TW201617315A (zh) 2016-05-16
US20170204058A1 (en) 2017-07-20
KR20170032338A (ko) 2017-03-22
UY36221A (es) 2016-02-29
CN106536513A (zh) 2017-03-22

Similar Documents

Publication Publication Date Title
CR20170005A (es) Derivados de insoindolina
CL2017000152A1 (es) Derivados de isoindolinona
MX2022009148A (es) Composiciones y metodos para el tratamiento de hemoglobinopatias.
CL2016003398A1 (es) Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo.
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
EA201891211A1 (ru) Ингибиторы cxcr2
CL2016003263A1 (es) Composiciones enriquecidas esteroquímicamente para la liberación de ácidos nucléicos.
CL2016002157A1 (es) Anticuerpos anti-cd38 para el tratamiento de leucemia linfoide aguda
PH12017500207A1 (en) Indoles for use in influenza virus infection
BR112017007636A2 (pt) métodos para a preparação de ribosídeos
DK3119762T3 (da) Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft
CL2015002855A1 (es) Derivados de oxopiridina sustituida.
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
MX2016003199A (es) Compuestos de azapiridona y usos de los mismos.
EA201790571A1 (ru) Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
JOP20170169A1 (ar) مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
MX2016011160A (es) Tratamiento de afecciones asociadas con la hiperinsulinemia.
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
CL2017000151A1 (es) Derivados de piridona
CL2016000038A1 (es) Piraxolo-piridinaminas sustituidas
MX2017004655A (es) Compuestos de hidroxil purinas y aplicaciones de estos.
CL2017000484A1 (es) Compuestos de azetidiniloxifenilpirrolidina
HUE042043T2 (hu) Malária megelõzésére vagy kezelésére alkalmas triaminopiridin-vegyületek